#1 Clinical Trials Search in Europe

Dobutamine

Dobutamine is a medication commonly used in clinical trials to evaluate and treat various cardiac conditions. This article explores recent clinical trials investigating the effects of dobutamine on heart function, blood flow, and patient outcomes across different cardiac disorders. From assessing its impact on patients with heart failure to studying its use in stress echocardiography, these trials aim to better understand how dobutamine can be utilized to improve cardiac care and management.

Table of Contents

What is Dobutamine?

Dobutamine is a medication used to treat heart conditions and improve blood flow in certain medical situations. It is known by several names, including Dobutrex[1]. Dobutamine belongs to a class of drugs called inotropes, which help strengthen heart contractions[2].

How Dobutamine Works

Dobutamine works by stimulating receptors in the heart and blood vessels. This stimulation causes the heart to beat more strongly and efficiently, increasing the amount of blood pumped out with each heartbeat. It also helps widen blood vessels, allowing for better blood flow throughout the body[3].

Medical Uses of Dobutamine

Dobutamine is used in various medical situations, including:

  • Heart failure: It can help improve heart function in patients with acute or chronic heart failure[4].
  • Sepsis and septic shock: Dobutamine may be used to improve blood flow in patients with severe infections that affect the whole body[2].
  • Cardiac surgery: It can help support heart function after heart surgeries, such as aortic valve replacement[4].
  • Stress testing: Dobutamine is sometimes used during cardiac stress tests to evaluate heart function[5].
  • Improving tissue oxygenation: In some surgical procedures, like breast reconstruction, dobutamine may be used to enhance blood flow and oxygen delivery to tissues[6].

How Dobutamine is Administered

Dobutamine is typically given through an intravenous (IV) line directly into a vein. The dosage and duration of treatment vary depending on the specific medical situation and the patient’s response. Some key points about dobutamine administration include:

  • It is usually given as a continuous infusion, with the dose adjusted based on the patient’s heart rate, blood pressure, and other factors[3].
  • Dosages can range from 2.5 to 40 micrograms per kilogram of body weight per minute[1].
  • The medication is often used for short periods, such as during surgery or in emergency situations, but may be used for longer periods in some cases[6].

Potential Side Effects

While dobutamine can be very beneficial in certain medical situations, it can also cause side effects. Some potential side effects include:

  • Increased heart rate (tachycardia): This is one of the most common side effects and is closely monitored during treatment[6].
  • Changes in blood pressure: Dobutamine can cause increases or decreases in blood pressure[3].
  • Arrhythmias: Irregular heart rhythms may occur in some patients[2].
  • Headache or nausea: Some patients may experience these symptoms during treatment[6].

Healthcare providers closely monitor patients receiving dobutamine to minimize the risk of side effects and adjust the treatment as needed.

Ongoing Research and Future Applications

Researchers are continually studying dobutamine to better understand its effects and explore new potential uses. Some areas of ongoing research include:

  • Cardiac function in specific patient groups: Studies are investigating how dobutamine affects heart function in patients with conditions like wild-type transthyretin amyloid cardiomyopathy (ATTRwt)[1].
  • Liver blood flow: Researchers are examining how dobutamine impacts blood flow to the liver during certain surgical procedures[3].
  • Pediatric use: Studies are comparing dobutamine to other medications for managing low cardiac output in critically ill children[7].
  • Tissue oxygenation: Investigations are underway to determine if dobutamine can improve oxygen delivery to tissues during specific surgeries, such as breast reconstruction[6].

These ongoing studies may lead to new applications for dobutamine and improve our understanding of how to use it most effectively in different medical situations.

Study Focus Patient Population Key Findings/Objectives
ATTRwt Cardiomyopathy Patients with wild-type transthyretin amyloid cardiomyopathy Investigating effects of dobutamine on cardiac output and filling pressures
Sepsis Patients with sepsis and persistent hypoperfusion Evaluating dobutamine’s impact on renal function and organ perfusion
Hepatic Blood Flow Patients undergoing pancreaticoduodenectomy Assessing dobutamine’s effect on hepatic blood flow during surgery
Cardiac Conduction Patients undergoing electrophysiology studies Studying dobutamine’s effects on cardiac conduction system
Neonatal Hemodynamics Premature infants with hemodynamic insufficiency Investigating dobutamine for treating circulatory impairment in newborns
Pediatric Low Cardiac Output Critically ill pediatric patients with low cardiac output Comparing dobutamine to milrinone for managing low cardiac output
Tetralogy of Fallot Patients with repaired Tetralogy of Fallot Using dobutamine stress testing to assess right ventricular function
Metabolic Syndrome and Diabetes Patients with metabolic syndrome or type 2 diabetes Evaluating myocardial function during dobutamine stress echocardiography
Post-Aortic Valve Replacement Patients after aortic valve replacement surgery Examining dobutamine’s effects on postoperative cardiac function

FAQ

  • What is dobutamine and how does it work? Dobutamine is a medication that stimulates the heart to pump more strongly. It works by activating receptors in the heart muscle, causing it to contract more forcefully and increasing cardiac output.
  • In which cardiac conditions is dobutamine being studied? Dobutamine is being studied in various cardiac conditions including heart failure, sepsis, transthyretin amyloid cardiomyopathy, tetralogy of Fallot, and in patients undergoing cardiac surgery like aortic valve replacement.
  • How is dobutamine administered in clinical trials? In most trials, dobutamine is administered intravenously as a continuous infusion. The dosage is often gradually increased and adjusted based on the patient's response and the specific study protocol.
  • What are some potential benefits of dobutamine observed in trials? Some potential benefits observed include increased cardiac output, improved blood flow to organs, enhanced myocardial contractility, and better overall heart function in certain patient groups.
  • Are there any risks or side effects associated with dobutamine use? While generally well-tolerated, dobutamine can cause side effects such as increased heart rate, changes in blood pressure, and arrhythmias. The trials closely monitor patients for any adverse effects during administration.

Ongoing Clinical Trials on Dobutamine

  • Study on Esmolol Hydrochloride, Dobutamine, and Milrinone for Patients with Cardiogenic Shock on V-A ECMO Support

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on the Effects of Dobutamine on Heart Function in Patients with Wild-type Transthyretin Amyloid Cardiomyopathy

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on the Effectiveness of High-Dose Vitamin C for Patients with Shock After Cardiac Arrest

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Finding the Right Dose of Dobutamine for Very Preterm Infants with Heart and Blood Flow Issues

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study Comparing Norepinephrine and Dobutamine for Patients with Cardiogenic Shock

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on Dobutamine and Tocilizumab for Patients with Heart Attack at High Risk of Cardiogenic Shock

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on the Safety and Effectiveness of Cipepofol Compared to Propofol for General Anesthesia in Adults Undergoing Elective Surgery

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Poland Spain

Glossary

  • Cardiac output: The amount of blood pumped by the heart per minute. It's a key measure of heart function.
  • Echocardiography: An imaging technique that uses sound waves to create pictures of the heart, allowing doctors to assess its structure and function.
  • Inotropic therapy: Treatment that affects the force of heart muscle contractions. Dobutamine is an example of a positive inotrope, which increases the heart's pumping strength.
  • Pulmonary artery wedge pressure (PAWP): A measurement that reflects the pressure in the left atrium of the heart, used to assess heart function and fluid status.
  • Sepsis: A life-threatening condition caused by the body's extreme response to an infection, which can lead to organ failure.
  • Stroke volume: The amount of blood pumped out of the heart with each beat.
  • Systolic function: The heart's ability to contract and pump blood out to the body.
  • Tetralogy of Fallot: A congenital heart defect that involves four anatomical abnormalities of the heart.
  • Transthyretin amyloid cardiomyopathy (ATTRwt): A type of heart disease caused by deposits of abnormal proteins (amyloids) in the heart muscle.
  • Ventricular remodeling: Changes in the size, shape, and function of the heart, often occurring after heart injury or in heart disease.

References

  1. https://clinicaltrials.gov/study/NCT06318260
  2. https://clinicaltrials.gov/study/NCT05953142
  3. https://clinicaltrials.gov/study/NCT04893655
  4. https://clinicaltrials.gov/study/NCT01375335
  5. https://clinicaltrials.gov/study/NCT02505451
  6. https://clinicaltrials.gov/study/NCT04020172
  7. https://clinicaltrials.gov/study/NCT05999487